LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Akcijų sąrašas・Intuitive Surgical Inc

Intuitive Surgical Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

424.07 0.17

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

419.65

Max

425.8

Pagrindiniai rodikliai
By Trading Economics
Pajamos	22M 822M
Pardavimai	-95M 2.8B
P/E Sektoriaus vid.	53.168 50.102
Pelnas, tenkantis vienai akcijai	2.5
Pelno marža	29.648
Darbuotojai	17,021
EBITDA	-230M 855M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+34.46% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-07-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-10B 155B
Ankstesnė atidarymo kaina	423.9
Ankstesnė uždarymo kaina	424.07

Naujienos nuotaikos

By Acuity

39%

61%

112 / 344 reitingas Healthcare

Intuitive Surgical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-22 15:47; UTC

Pagrindinės rinkos jėgos

Intuitive Surgical Shares Rise After 1Q Beat

2026-04-21 20:54; UTC

Uždarbis

Intuitive Surgical Posts Higher 1Q Sales, Profit

2026-04-22 11:27; UTC

Uždarbis

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

2026-04-21 21:14; UTC

Uždarbis

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

2026-04-21 20:38; UTC

Uždarbis

Intuitive Surgical 1Q Rev $2.77B >ISRG

2026-04-21 20:38; UTC

Uždarbis

Intuitive Surgical 1Q Net $821.5M >ISRG

2026-04-21 20:38; UTC

Uždarbis

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

2026-04-21 20:38; UTC

Uždarbis

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

2026-04-21 20:38; UTC

Uždarbis

Intuitive Surgical 1Q EPS $2.28 >ISRG

2026-04-21 20:14; UTC

Uždarbis

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

2026-04-21 20:14; UTC

Uždarbis

Intuitive Surgical 1Q Rev $2.77B

2026-04-21 20:13; UTC

Uždarbis

Intuitive Surgical 1Q Adj EPS $2.50

2026-04-21 20:12; UTC

Uždarbis

Intuitive Surgical 1Q EPS $2.28

2026-04-14 14:13; UTC

Uždarbis

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

2026-04-14 12:57; UTC

Uždarbis

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

2026-02-17 14:48; UTC

Uždarbis

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026-01-23 16:07; UTC

Uždarbis

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

2026-01-23 12:58; UTC

Uždarbis

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

2026-01-22 21:11; UTC

Uždarbis

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

2026-01-22 21:11; UTC

Uždarbis

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

2026-01-22 21:10; UTC

Uždarbis

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q EPS $2.21 >ISRG

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Rev $2.87B >ISRG

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Net $794.8M >ISRG

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

2026-01-22 21:05; UTC

Uždarbis

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

2025-10-30 12:38; UTC

Uždarbis

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

2025-10-30 12:01; UTC

Uždarbis

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

2025-10-22 15:42; UTC

Uždarbis

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

2025-10-22 12:34; UTC

Uždarbis

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Intuitive Surgical Inc Prognozė

Kainos tikslas

By TipRanks

34.46% į viršų

12 mėnesių prognozė

Vidutinis 569.61 USD 34.46%

Aukščiausias 670 USD

Žemiausias 451 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Intuitive Surgical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

20 ratings

Pirkti

Laikyti

Parduoti

Remiantis 20 analitikų, pateikusių Intuitive Surgical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

112 / 344 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.